Limited Focus in Evaluation of Vaccine Cost-effectiveness

被引：0

作者：

Curran, Desmond ^{[1
]}

Van Oorschot, Desiree ^{[1
]}

Buck, Philip ^{[2
]}

机构：

[1] GSK, Wavre, Belgium

[2] GSK, Philadelphia, PA USA

来源：

JAMA INTERNAL MEDICINE | 2018年 / 178卷 / 11期

关键词：

ZOSTER VACCINE;

D O I：

10.1001/jamainternmed.2018.5801

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1563 / 1564

页数：5

共 5 条

[1] Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States [J].

Curran, D. ;

Patterson, B. ;

Varghese, L. ;

Van Oorschot, D. ;

Buck, P. ;

Carrico, J. ;

Hicks, K. ;

Lee, B. ;

Yawn, B. .

VACCINE, 2018, 36 (33) :5037-5045

[2] Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines [J].

Dooling, Kathleen L. ;

Guo, Angela ;

Patel, Manisha ;

Lee, Grace M. ;

Moore, Kelly ;

Belongia, Edward A. ;

Harpaz, Rafael .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (03) :103-108

[3] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults [J].

Le, Phuc ;

Rothberg, Michael B. .

JAMA INTERNAL MEDICINE, 2018, 178 (02) :248-258

[4] Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine [J].

Phuc Le ;

Rothberg, Michael B. .

JAMA INTERNAL MEDICINE, 2018, 178 (09) :1277-1278

[5] Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years [J].

Phuc Le ;

Rothberg, Michael B. .

ANNALS OF INTERNAL MEDICINE, 2015, 163 (07) :489-+

← 1 →